Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.80

€1.80

2.720%
0.05
2.720%
€2.50

€2.50

 
01.12.21 / Tradegate WKN: A2DYQV / Symbol: OPXA / Name: Acer Therapeutics / Stock / Biotechnology & Medical Research / Micro Cap /
Latest predictions
€2.50
01.11.21
-12.75%
buy
09.08.21
-23.73%
buy
29.03.21
-28.00%
Best running prediction
-
29.03.21
-28.00%
Your prediction

Acer Therapeutics Inc Stock

There is an upward development for Acer Therapeutics Inc compared to yesterday, with an increase of €0.050 (2.720%).
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Acer Therapeutics Inc.
With a target price of €2.00 there is a slightly positive potential of 11.111% for Acer Therapeutics Inc compared to the current price of €1.80.
Our community identified positive and negative aspects for Acer Therapeutics Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Acer Therapeutics Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Acer Therapeutics Inc in the next few years

Pros
0
-
Cons
1
Risky Investment

Performance of Acer Therapeutics Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Acer Therapeutics Inc 2.720% -16.832% -18.447% - - - -
Celldex Therapeutics 3.820% -9.766% -23.338% 75.751% 125.714% 707.152% -35.929%
Lipocine Inc -0.330% -9.658% -2.125% -30.923% -16.852% - -
Acura Pharmaceuticals - -4.813% -2.198% 128.205% 169.697% 159.854% -55.886%

Other discussions about Acer Therapeutics Inc Stock

New thread Forum